Company intelligence / Profile preview

Concept Life Sciences

Sandwich, England, United Kingdomconceptlifesciences.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Concept Life Sciences is not a drug developer but has supported the advancement of at least: ~44 candidates to preclinical stage, ~28–30 candidates to clinic, ~4–5 drugs to market for its clients as of recent reporting.

Therapeutic areas: ImmunologyOncologyGastroenterologyNeurology
Modalities: Small moleculeProteinPeptideOligonucleotideCell therapyGene therapyAntibody-drug conjugatecustom peptide synthesistargeted protein degradationprodrugstherapeutic antibody development
Industry: Contract Research Organization

Beyond the preview

Go deeper on Concept Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concept Life Sciences.